Abstract
AbstractThere are significant disparities with regards to incidence, timely diagnosis, access to treatment, clinical trial participation and health care utilization that negatively impact outcomes for African American patients with multiple myeloma. Health care providers have a role in ameliorating these disparities with thoughtful consideration of historical, sociocultural, individual and disease characteristics that influence the care provided to African American patient population. This review by a group of experts committed to health disparity in multiple myeloma provides a snapshot of disparities at both biologic and non-biologic levels, barriers to clinical care, and best practices to ensure that African American patients receive the best care available.
Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. McBean AM, Gornick M. Differences by race in the rates of procedures performed in hospitals for medicare beneficiaries. Health Care Financ Rev. 1994;15:77–90.
2. Fiala MA, Wildes TM. Racial disparities in treatment use for multiple myeloma. Cancer. 2017;123:1590–6.
3. Harris DR, Andrews R, Elixhauser A. Racial and gender differences in use of procedures for black and white hospitalized adults. Ethn Dis. 1997;7:91–105.
4. Vyas DA, Eisenstein LG, Jones DS. Hidden in plain sight—reconsidering the use of race correction in clinical algorithms. N Engl J Med. 2020;383:874–82.
5. Amutah C, Greenidge K, Mante A, Munyikwa M, Surya SL, Higginbotham E, et al. Misrepresenting race - the role of medical schools in propagating physician bias. N Engl J Med. 2021;384:872–8.